Chadha Renu, Sharma Mohit, Haneef Jamshed
University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Studies, Panjab University, Chandigarh, India.
J Pharm Pharmacol. 2017 Mar;69(3):254-264. doi: 10.1111/jphp.12685. Epub 2017 Jan 30.
This study aimed to improve biopharmaceutical parameters of the poorly soluble antihypertensive drug, felodipine, by preparing multicomponent solid forms using three coformers, viz. imidazole, nicotinamide and malonic acid.
The multicomponent solid forms were prepared by mechanochemical synthesis and characterised by various analytical techniques. These solid forms were further assessed for their physicochemical parameters. Pharmacokinetic and in-vivo antihypertensive activity was performed in rats.
Felodipine (FEL) was found to be cocrystallised with imidazole (FEL-IM) while it formed eutectic with nicotinamide (FEL-NCT) and malonic acid (FEL-MA). Cocrystal was sustained by NH…N and NH….O hydrogen-bonded network. Solubility and intrinsic dissolution studies in 0.1 N HCl (pH 1.2) revealed that eutectics exhibited higher solubility and release rate than cocrystal vis-a-vis pure drug and were found to be stable under accelerated storage condition. Significant enhancement of bioavailability was observed in eutectics (3.5- to twofold) and cocrystal (1.3-fold) compared with the pure drug. Antihypertensive activity of new solid forms in an animal model showed a marked decrease in systolic blood pressure.
Mechanochemical approach was successful to prepare multicomponent solid forms that have the potential to improve biopharmaceutical parameters of the poorly soluble drug, FEL.
本研究旨在通过使用三种共形成物,即咪唑、烟酰胺和丙二酸制备多组分固体形式,来改善难溶性抗高血压药物非洛地平的生物药剂学参数。
通过机械化学合成制备多组分固体形式,并采用各种分析技术对其进行表征。进一步评估这些固体形式的物理化学参数。在大鼠中进行药代动力学和体内抗高血压活性研究。
发现非洛地平(FEL)与咪唑形成共晶体(FEL-IM),而与烟酰胺(FEL-NCT)和丙二酸(FEL-MA)形成低共熔物。共晶体由NH…N和NH….O氢键网络维持。在0.1 N HCl(pH 1.2)中的溶解度和固有溶出度研究表明,相对于纯药物,低共熔物表现出比共晶体更高的溶解度和释放速率,并且在加速储存条件下被发现是稳定的。与纯药物相比,低共熔物(3.5至两倍)和共晶体(1.3倍)的生物利用度显著提高。新固体形式在动物模型中的抗高血压活性显示收缩压显著降低。
机械化学方法成功制备了多组分固体形式,这些固体形式有可能改善难溶性药物非洛地平的生物药剂学参数。